Invex Therapeutics Ltd


Invex Therapeutics Ltd (ASX: IXC) a biopharmaceutical company, concentrates on developing effective treatments for neurological conditions, which is caused by raised intracranial pressure (ICP). ICP is considered as a serious issue in a range of neurological conditions, which includes idiopathic intracranial hypertension (IIH), traumatic brain injury or severe stroke. The company was established in March 2019 and is headquartered in Australia.

Contact Information

company address Level 1, 38 Rowland Street, SUBIACO, WA, AUSTRALIA, 6008

company phone+61 8 6382 0137

company website

Similar Companies

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK